FIELD: biotechnology, medicine, oncology, peptides.
SUBSTANCE: invention relates to a method based on phage display for preparing peptides interacting specifically with mammary Ehrlich tumor and can be used in therapy and diagnosis of malignant neoplasm. Peptides are prepared by affinity selection from phage peptide libraries comprising ten millions of different peptides of size 15 amino acid residues, the group of nine peptides wherein each peptide shows ability for accumulation in Ehrlich tumor. For practice using mimetic-peptides selected by such manner can be prepared by chemical synthesis and to use for preparing conjugates on their basis with the known cytotoxic preparations, radioactive isotopes and they can be incorporated in the composition of liposomal preparations for visualization of tumor neoplasm also.
EFFECT: valuable medicinal properties of peptides.
2 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
TUMOR-TARGETED PEPTIDE | 2004 |
|
RU2273644C2 |
TUMOUR-SPECIFIC PEPTIDE FOR ADDRESS CHEMOTHERAPY OF HUMAN BREAST CANCER | 2015 |
|
RU2595404C1 |
IMMUNOMIMETIC PEPTIDE OF CHEMICAL CANCEROGENS WITH SPECIFIC INTERACTION EFFECT ON ANTIBODIES OF BENZO[α]PYRENE AND BENZO[α]ANTHRACENE | 2007 |
|
RU2357975C1 |
PEPTIDE-SIMULATOR OF PROTEIN GP120 HIV-1 EPITOPE | 2000 |
|
RU2184780C2 |
PEPTIDE-SIMULATOR OF HUMAN IMMUNODEFICIENCY TYPE-1 VIRUS PROTEIN GP41 CONSERVATIVE EPITOPE RECOGNIZED BY VIRUS-NEUTRALIZING MONOCLONAL ANTIBODY 2F5 (VARIANTS) | 2000 |
|
RU2179980C2 |
SCREENING METHODS AND THEIR APPLICATION | 2012 |
|
RU2622089C2 |
AGENT FOR NEUTRALISING SMALLPOX VIRUS | 2013 |
|
RU2515905C1 |
RECOMBINANT FRAGMID DNA pHEN-TAB CONTAINING HUMAN SINGLE-STRAND ANTIBODY GENE, CAPABLE OF BINDING OF HUMAN TUMOR NECROSIS FACTOR ALPHA; RECOMBINANT Escherichia coli BACTERIA STRAIN AS PRODUCER OF HUMAN SINGLE-STRAND ANTIBODY AGAINST HUMAN TUMOR NECROSIS FACTOR ALPHA; RECOMBINANT SOLUBLE HUMAN SINGLE-STRAND ANTIBODY AGAINST HUMAN TUMOR NECROSIS FACTOR ALPHA | 2005 |
|
RU2307163C2 |
METHOD FOR IDENTIFICATION OF BACTERIOPHAGE, METHOD FOR ISOLATION OF MAMMAL CELLS, METHOD FOR SELECTION OF BACTERIOPHAGE (VARIANTS), METHOD FOR IDENTIFICATION OF BACTERIOPHAGE SUBGROUP AND INTERNALIZING LIGAND (VARIANTS) | 1998 |
|
RU2234530C2 |
METHOD OF PRODUCING PEPTIDES SPECIFICALLY IDENTIFYING CERTAIN TYPES OF CELLS AND INTENDED FOR THERAPEUTIC PURPOSES | 2009 |
|
RU2528739C2 |
Authors
Dates
2005-11-27—Published
2003-11-14—Filed